Zenas BioPharma, Inc. ZBIO
$18.40
▲ +11.49% 24H
About
Zenas BioPharma, Inc. is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of transformative therapies for autoimmune diseases. The company focuses on advancing innovative immunology-based treatments, with a strong commitment to addressing diseases characterized by significan…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees167
TickerZBIO
Statistics
Market Cap$1.15B
Revenue (TTM)$10.0M
Net Income-$377.7M
Net Margin-3777.4%
EPS$-8.44
P/E1.63
P/S112.12
P/B2.94
EV/EBITDA-2.83
ROE-137.1%
Dividend Yield0.05%
Price$18.40
Data: Twelve Data · Revenue = mcap / P/S